Find investors
← Back to all investors
Kevin Xu
ResearchedAngel Investors

Kevin Xu

Vice President

Angel InvestorsSeed Round
Pitch Kevin

Get their honest, personalized take on your startup.

Sign in to pitch Kevin

At a glance

Full Name
Kevin Xu
Title
Partner (promoted to Principal in Nov 2023; Vice President at the time of the 2019 Alpha-H deal)
Firm
The Riverside Company — Riverside Australia Fund (RAF)
Firm Type
Private equity (lower/middle-market control buyouts and growth capital) — *note: the "Angel Investor / Seed" descriptors in the stub are inaccurate; Riverside is a global control-buyout PE firm*
Investment Stage
Control buyouts and growth investments in established, profitable companies (not seed-stage)
Check Size
Riverside Australia targets companies with EBITDA up to ~A$25 million (equity checks typically in the tens of millions AUD)
Target Company Profile
Founder-led, high-growth, profitable Australian and New Zealand businesses at the smaller end of the middle market
Sector Focus
Business Services, Healthcare, Software & Technology, Specialty Manufacturing & Distribution; personally active in biotech/clinical research, e-learning, healthcare, energy software and consumer
Geographic Focus
Australia and New Zealand
Location
Melbourne, Australia (Level 21, 101 Collins Street)

Background

Kevin Xu is a Partner in the Melbourne office of The Riverside Company, a global private-equity firm founded in 1988 that focuses on the smaller end of the middle market and has completed more than 980 investments across its history. He works within the Riverside Australia Fund (RAF), which launched in 2010, has completed roughly 40 investments, and backs founder-led ANZ businesses with EBITDA up to A$25 million across Business Services, Healthcare, Software & Technology, and Specialty Manufacturing & Distribution.

Xu joined Riverside in 2014 and has spent the subsequent decade working across the full deal lifecycle — new platform investments, bolt-on acquisitions and divestitures. He was promoted to Principal in November 2023 (announced alongside new RAF hires including James Elsom, Hannah Davies and Dominique Ling) and is now listed as a Partner. On his promotion he said, "Over the past decade with the Riverside Australia Fund, I have witnessed first-hand the positive impact of the firm's global connectivity and partnership model."

Before Riverside, Xu began his career in finance as an Investment Banking Analyst at J.P. Morgan, completing the bank's analyst training in New York in 2012. He holds a Bachelor of Commerce and Bachelor of Laws (Honours) from the University of Melbourne (2007–2011) and completed his secondary schooling at Westbourne Grammar School. He is a native Mandarin and English speaker and earlier did volunteer legal work at the Moreland/Merri-bek community legal service.

Beyond sourcing and executing deals, Xu serves as an investor and Non-Executive Director on several RAF portfolio boards, giving him hands-on governance experience across healthcare, IT services and industrial-software businesses.

Investment Thesis & Focus

  • Control and growth PE, not venture/seed: partners with established, profitable ANZ companies rather than pre-revenue startups; the mandate targets EBITDA up to ~A$25M.
  • Founder partnership model: RAF backs entrepreneurial founders of "high-growth, profitable" ANZ businesses, positioning Riverside's global network and buy-and-build playbook as the value-add.
  • Sector lens: Business Services, Healthcare, Software & Technology, and Specialty Manufacturing & Distribution; Xu's personal deals skew toward healthcare/clinical research, energy-market software, e-learning and consumer.
  • Buy-and-build: heavy use of bolt-on M&A to scale platforms, with a defined path to exit (trade sale or secondary buyout).
  • Global connectivity: Xu explicitly cites Riverside's "global connectivity and partnership model" as the firm's differentiator for ANZ founders looking to expand internationally.

Notable Investments

  • Alpha-H — Queensland premium skincare brand (Liquid Gold line); Riverside invested in April 2019 (Xu worked the deal as VP) and exited to Hong Kong's Vita Green in 2025.
  • Energy Exemplar — Adelaide-founded provider of energy-market simulation/modeling software (PLEXOS); a marquee RAF technology holding.
  • Avance Clinical — specialist Australian contract research organization (CRO); Xu is an investor and Non-Executive Director.
  • Virtual IT Group (VITG) — managed IT services provider that took on Riverside investment to fund growth; Xu is an investor/NED.
  • DINGO — predictive-maintenance software for heavy industry; Xu is an investor and Non-Executive Director.
  • Altius Group — provider of occupational rehabilitation and allied-health services.
  • Waste Services Group — waste-management platform noted among his prior deal roles.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.